Depression and Injection site necrosis

Summary:

Injection site necrosis is found among people with Depression, especially for people who are female, 50-59 old.

The study analyzes which people have Injection site necrosis with Depression. It is created by eHealthMe based on reports of 32 people who have Depression from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Depression?

Depression is found to be associated with 3,167 drugs and 4,125 conditions by eHealthMe. Check the latest studies of Depression.

What is Injection site necrosis?

Injection site necrosis (death of body tissue at injection site) is found to be associated with 139 drugs and 314 conditions by eHealthMe. Check the latest studies of Injection site necrosis.

On Jul, 09, 2026

32 people who have Depression and Injection Site Necrosis are studied.

Would you have Injection site necrosis when you have Depression?

Gender of people who have Depression and experienced Injection Site Necrosis *:

female: 65.62 %
male: 34.38 %

Age of people who have Depression and experienced Injection Site Necrosis *:

Common co-existing conditions for these people *:

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 13 people, 40.62%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 9 people, 28.12%
Pain: 8 people, 25.00%
High Blood Cholesterol: 6 people, 18.75%
Stress And Anxiety: 5 people, 15.62%
High Blood Pressure: 5 people, 15.62%
Sleep Disorder: 5 people, 15.62%
Muscle Spasms (muscle contraction): 4 people, 12.50%
Diabetes: 4 people, 12.50%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 9.38%

Common drugs taken by these people *:

Common symptoms for these people *:

Injection Site Pain: 16 people, 50.00%
Injection Site Erythema (redness at injection site): 9 people, 28.12%
Injection Site Infection: 9 people, 28.12%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 21.88%
Injection Site Abscess: 7 people, 21.88%
Fatigue (feeling of tiredness): 6 people, 18.75%
Injection Site Discoloration: 6 people, 18.75%
Weight Decreased: 5 people, 15.62%
Pain In Extremity: 5 people, 15.62%
Injection Site Cellulitis (injection site inflammation): 5 people, 15.62%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Injection site necrosis?

- Check whether Injection site necrosis is associated with a drug or a condition

Related publications that referenced our studies

Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .

Related studies:

Treatments, associated drugs and conditions:

Depression (652,144 reports)
Injection site necrosis (2,811 reports)

All the drugs that are associated with Injection site necrosis:

Injection site necrosis (139 drugs)

All the conditions that are associated with Injection site necrosis:

Injection site necrosis (314 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Injection site necrosis and Depression, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.